Association between BNT162b2 vaccination and reported incidence of post-COVID-19 symptoms: cross-sectional study 2020-21, Israel

The effectiveness of Coronavirus disease 2019 (COVID-19) vaccines against the long-term COVID-19 symptoms expressed by a substantial proportion of patients is not well understood. We determined whether vaccination with the BNT162b2 mRNA vaccine was associated with incidence of reporting long-term sy...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuodi, Paul, Gorelik, Yanay, Zayyad, Hiba, Wertheim, Ofir, Wiegler, Karine Beiruti, Abu Jabal, Kamal, Dror, Amiel A., Nazzal, Saleh, Glikman, Daniel, Edelstein, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411827/
https://www.ncbi.nlm.nih.gov/pubmed/36028498
http://dx.doi.org/10.1038/s41541-022-00526-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411827/
https://www.ncbi.nlm.nih.gov/pubmed/36028498
http://dx.doi.org/10.1038/s41541-022-00526-5

Ejemplares similares